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GWAS in myopia: insights into disease and implications for the clinic 
 
Summary 
Myopia is the commonest eye trait worldwide and the prevalence is increasing. It 
is known to be highly heritable; total genetic variation explains up to 70-80% of 
variance. In an attempt to better understand the genetic architecture of myopia, 
with an ultimate view to better predict genetic risk and develop targeted 
treatments, several genome-wide association studies have been performed in the 
last 6 years. In this review we focus on what a genome-wide association study 
involves, what studies have been performed in relation to myopia to date, and 
what they ultimately tell us about myopia variance and functional pathways 
leading to pathogenesis. The current limitations of genome-wide association 
studies are reviewed and potential means to improve our understanding of the 
genetic factors for myopia are described. 
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Introduction 
Myopia is already the commonest eye condition and its prevalence is increasing 
across the world (1-4). Refractive error is the term used to describe an error in 
the accurate focusing of light onto the retinal plane. Myopia, or near-sightedness, 
typically results from axial elongation of the eyeball and this results in an image 
forming anterior to the retinal plane, hyperopia results when an image lies 
posterior to the retinal plane.  Although myopia is strongly associated with a 
number of environmental factors, the most important risk factor in determining 
whether an individual develops the trait is a family history of myopia, suggesting 
a genetic predisposition. The heritability of a trait is an estimate of how much 
phenotypic variation in a population is due to genetic factors. The heritability of 
refractive error, using spherical equivalent as a quantitative trait, has been 
determined in a number of family and, more credibly, twin studies [Figure 1]. 
These indicate the heritability of myopia is high at around 70% (5-15).  
 
Figure 1 Heritability estimates for refractive error (Abbreviations: T = twin 
studies, F = family studies). 
 
Myopia is a complex trait influenced by a complicated interplay of genetic and 
environmental factors. As with many complex traits there is a distribution of 
refractive error in the population, meaning the risk of ordinary or “simple” myopia 
developing is not determined by a classic Mendelian single gene mode of 
inheritance; there are likely many genes, each contributing a small effect to overall 
myopia risk. This may not be true for very high, familial or syndrome-associated 
forms of myopia – in these cases a rare dominantly inherited mutation may be 
important in an individual family, but not important in the overall population risk. 
Up until the era of genome-wide association studies (GWAS), identification of 
disease-associated genes relied on family studies (using linkage analysis) or 
candidate gene studies. In myopia, these were singularly unsuccessful and prior 
to 2009 there were no known myopia-associated genes, other than syndromes 
where myopia was a part of the phenotypic spectrum (eg Stickler’s, Marfan 
syndromes). However, with the advent of GWAS, a number of genes for myopia 
have been identified, providing new insight into how myopia develops with 
implications for future research into how this increasingly common eye trait 
might be treated.  
 
Genome-wide association studies (GWAS) 
Genome-wide association studies (GWAS) are approaches that allow a vast array 
of markers scattered across an individual’s DNA or genome to be rapidly tested 
for association with a disease or trait. These ‘markers’ are variations in the base 
pair of nucleotides at specific points along the genome, commonly known as SNPs 
(single-nucleotide polymorphisms), and give an indication of what nearby genes 
may be associated with the trait. 
 
In order for this analysis technique to be possible, all of the base pairs, namely 
adenine (A), guanine (G), thymine (T) or cytosine (C), forming the human DNA 
code had to be sequenced (ie. read and mapped). The human genome project, 
completed in 2003, was a major international scientific collaboration that 
identified all of the base pairs and genes that make up the human genome, 
approximately 20,500 genes in total (16, 17). This has enabled researchers to have 
access to a detailed resource on the structure, function and organization of the 
complete set of genes that make up the human species. However, to investigate 
the association between the human genome and disease, a ‘map’ of common 
patterns of genetic variation and inheritance was required, known as a ‘haplotype 
map’. This was firstly provided by the HapMap project, completed in 2005 (18); 
this international project compared the genetic sequences of individuals of 
African, Asian and European ancestry. Subsequently the 1000 Genome Project, 
which harnessed the increased speed, greater coverage and reduced cost of next-
generation sequencing, was launched. Released in 2012 this has provided the 
most detailed catalogue of human genetic variation to date with sequencing of 
over 1000 participants internationally (19). These maps of common inheritance 
patterns allow identification of what base pair is commonly at one position in the 
genome of a certain ethnic population, the ‘common’ allele, and what base pair 
tends not be at that position, the ‘minor’ allele. SNPs are generally termed a 
common polymorphism when the frequency of the minor allele, in a specific 
population, is greater than 1%.  
 
GWAS rely upon the assumption that common complex traits are caused by 
common genetic variations in the population (the “common disease common 
variant” hypothesis). Therefore, in a GWAS the association between a trait and 
common genetic variants in the form of SNPs are examined. SNPs are not disease-
causing mutations, as found in classical genetic studies of rare Mendelian diseases, 
and they rarely alter protein structure or function, but instead they may relate to 
regulation of genes or alterations in gene expression. In GWAS SNPs are used as 
markers and indicate nearby genes or biological pathways that may be involved, 
allowing researchers to focus in on specific parts of the genome. 
 
To perform a GWAS for a disease, an individual must be genotyped or sequenced; 
in large-scale genetic studies this is generally undertaken with the use of high-
throughput genotyping arrays or chips. These provide an output of somewhere 
between 500,000 and 2,500,000 SNPs for that individual, but obviously do not 
include all the common genetic variants (given there are around 3 billion base 
pairs in the human genome). The missing data is therefore imputed using 
reference haplotypes, either the HapMap or 1000 Genome data. Associations 
between these genetic variations, following extensive data cleaning (quality 
control), and disease status is examined in regression models either as a 
quantitative trait (eg. refractive error measured by spherical equivalent) or as a 
categorical case-control trait (eg. ‘myopia’ or ‘no myopia’). The output from such 
analyses is a list of associated SNPs with an indication of the strength of effect on 
myopia risk (the beta coefficient) and the confidence of the association (p-value). 
Significance thresholds are set at less than p ≤ 5 10-8 to reduce the possibility of 
false positive associations, which may occur as a result of correlation between 
SNPs and the high number of statistical tests involved. This means large studies of 
many thousands of individuals are required to identify statistically significant 
associations. Results are generally portrayed graphically as a Manhattan plot, 
which plots all the SNPs by chromosome position as a function of their association 
p-value; this plot resembles the Manhattan skyline with different SNPs reaching 
higher than others, like skyscrapers, in accordance with variations in significance. 
Results of putative genetic associations for a trait (‘discovery stage’) must then be 
verified through replication of associated variants in independent population 
samples, or through experiments that can examine the functional implications of 
the affected gene. 
 
The first GWAS was performed in 2005 and since then there has been an 
exponential rise in the number of studies [Figure 2], reflecting the large reduction 
in time and cost of undertaking these types of analysis.  
 
Figure 2 Studies, traits and SNP-trait associations from 2005-2013 reveal the 
growth in genome-wide association studies. Adapted from (20), Copyright 
obtained. 
 
GWAS have now been successfully performed on a range of ophthalmic diseases 
(21, 22). The earliest and arguably the most ‘successful’ GWAS to date has been 
within the ophthalmic field; the discovery of the association of CFH with age-
related macular degeneration was reported in three independent cohorts in 2005 
(23-25), one of which was a GWAS, and has since been replicated in dozens of 
studies across the world. Subsequent meta-analysis involving large sample sizes 
(>17,100 cases and >60,000 controls) has identified 19 loci for AMD explaining 
10-30% of the variance (26), which has an estimated heritability of 45-70%. These 
genetic associations explain a relatively high proportion of AMD variance, which 
disappointingly has proved to be fairly unusual in subsequent GWAS for other 
traits. Although GWAS have identified many variants for many diseases, relatively 
small effects on disease risk are conferred for the majority of variants and only a 
small proportion of familial clustering or heritability is explained. This issue of 
‘missing heritability’ is a recurrent issue in GWAS and has prompted researchers 
to explore additional approaches to examine the genetic architecture of common 
complex diseases (27). 
 
Genome-wide association studies in myopia  
Refractive error and myopia have been examined using the full range of genetic 
methodologies. This initially included genome-wide linkage studies in related 
individuals, which have identified at least 17 loci, and candidate gene association 
studies which were rarely replicated (28-30). The first GWAS study to examine 
myopia was performed in 2009 on a cohort with high, pathological myopia; 
subsequent studies have either been performed on myopia case-control cohorts, 
largely from East Asia where the prevalence of myopia and high myopia is greater, 
or on cohorts with refractive error measured as a quantitative trait. The GWAS 
catalog database detailing all published GWAS for myopia, refractive error and 
other myopia endophenotypes was used to identify articles for this review 
(available at http://www.ebi.ac.uk/gwas/home). Articles included are 
summarized in Table 1. 
 
Table 1 Summary of published GWAS in myopia. † Associations not reaching 
conventional GWAS threshold (p ≤ 5 10-8) for statistical significance 
 
High Myopia GWAS 
The first published GWAS in myopia examined a Japanese population with 297 
cases of pathological myopia (defined as axial length > 26mm) and 977 controls 
from the general population (31). The strongest association was located at 
11q24.1, approximately 44kb upstream of the BLID gene, and conferred odds of 
higher myopia of 1.37 (95% confidence interval (CI) 1.21 - 1.54). Subsequently a 
meta-analysis of two ethnic Chinese cohorts, published in 2010, was performed 
for 287 cases of high myopia (defined as ≤ -6D) and 911 controls (32). The 
strongest association was an intronic SNP within the CTNND2 gene on 5p15.2. 
However neither of these initial associations met the conventional GWAS 
threshold (p ≤ 5 10-8) for statistical significance. 
 
Li et al also studied an ethnic Chinese population inclusive of 102 high-grade 
myopia cases (defined as ≤ -8D with retinal degeneration) and 335 controls (33). 
The strongest association (p = 7.70 x 10-13) was a high frequency variant located 
in a gene desert within the MYP11 myopia linkage locus on 4q25 (34). In a similar 
ethnic Han Chinese population of 419 high myopia cases (≤ -6D) and 669 controls, 
Shi et al identified the strongest association (p = 1.91 x 10-16) at an intronic, high 
frequency variant within the MIPEP gene on 13q12 (35). Although these studies 
attempted replication in independent cohorts, their results, published in 2011, 
have not been replicated in GWAS comprising of individuals of similar ethnic 
background, phenotypic definition or study design.  
 
In 2013 two papers reported replicated loci for high myopia in Asian populations. 
Shi et al studied a Han Chinese population of 665 cases with high myopia (≤ -6D) 
and 960 controls (36). Following two-stage replication in three independent 
cohorts the most significantly associated variant (p = 8.95 x 10-14) was in the 
VIPR2 gene within the MYP4 locus, and three further variants all reaching 
genome-wide significance were identified within the same linkage disequilibrium 
block in the SNTB1 gene (p = 1.13 x 10-8 to 2.13 x 10-11). Khor et al reported a meta-
analysis of four GWAS of East Asian ethnicity totalling 1603 cases of “severe” 
myopia (based on either refractive error or axial length) and 3427 controls (37). 
After replication analysis, the SNTB1 gene was confirmed and a novel variant 
within the ZFHX1B gene (also known as ZEB2) reached genome-wide significance 
(p = 5.79 x 10-10).  
 
In European populations, probably illustrating the lower prevalence of high 
myopia, there has only been one case-control GWAS from a French population, 
published in 2012. In this study of 192 high myopia cases (≤ -6D) and 1064 
controls a suggestive association was identified within the MYP10 linkage locus, 
3kb downstream of PPP1R3B, however this did not reach genome wide statistical 
significance and the study failed to replicate any of the previously reported loci 
(38).  
 
Refractive Error Quantitative GWAS. 
Greater success has been achieved by considering refractive error as a 
quantitative treat, including all subjects in population-based studies rather than a 
selected clinic-based sample of highly affected individuals. In 2010 the first two 
GWAS for refractive error were published, both in European populations; a British 
discovery cohort of 4270 individuals (39) and a Dutch discovery cohort of 5328 
individuals (40), with replication in over 10,000 individuals from the two 
discovery cohorts and a smaller shared pool of replication samples. Two loci 
surpassing the GWAS threshold were identified near the RASGFR1 gene on 
15q25.1 (p = 2.70 x 10-09) and the other near GJD2 on 15q14 (p = 2.21 x 10-14).  
Subsequently, in 2013, a relatively small meta-analysis was performed on 7280 
individuals from five cohorts with refractive error, inclusive of various ethnic 
populations across different continents. Replication was then undertaken in 
26,953 samples (41). A novel variant reaching the GWAS threshold was identified 
within the RBFOX1 gene on chromosome 16 was identified (p = 3.9 x 10-9). 
 
The field made a major breakthrough in 2013 when two major GWAS meta-
analysis studies were published. The Consortium for Refractive Error and Myopia 
(CREAM) is an international collaborative initiative between researchers studying 
cohorts of both European and Asian descent. A classic meta-analysis of the GWAS 
results for a linear regression between genotype and spherical equivalent of 
refractive error was performed for 35 participating centers, comprising 37,382 
individuals of European descent and 12,332 of Southeast Asian ancestry (42). 
High statistical power was achieved by this large sample size, enabling replication 
of the two loci previously identified and identification of 22 novel loci at genome-
wide significance [Figure 3]: BICC1, BMP2, BMP3, CACNA1D, CD55, CHD7, CHRNG, 
CNDP2, CYP26A1, GJD2, CRIA4, KCNJ2, KCNQ5, LAMA2, MYO1D, PCCA, PRSS56, 
RASGRF1, RDH5, RORB, SIX6, TOX, ZIC2 and ZMAT4. 
 
Figure 3 Manhattan plot of genetic associations for refractive error in the CREAM 
combined GWAS meta-analysis. -log10-transformed p values for all SNPs. The 
upper horizontal line indicates the p < 5.0 x 10-8 threshold, the lower horizontal 
line indicates a p value < 1 x 10-5 (adapted from (42)). 
 
A contemporaneous GWAS by the direct-to-consumer genomics company 
23andMe (Mountain View, CA, USA) using a survival analysis was performed on 
55,177 individuals of European descent using the phenotype of reported myopia 
and reported ‘age of spectacle wear’ as a proxy for myopia severity (43). The 
authors identified 20 novel loci: BMP3, BMP4, DLG2, DLX1, GJD2, KCNMA1, 
KCNQ5, LAMA2, LRRC4C, PABPCP2, PDE11A, PRSS56, RASGFR1, RBFOX1, RDH5, 
RGR, SFRP1, SHISA6, TJP2, TOX, ZBTB38 and ZIC2. Contrary to many researchers’ 
expectations, the authors identified highly comparable genetic associations to 
those obtained using the carefully and expensively collected refractive error data 
in population-based samples in the CREAM consortium. Of the 22 loci discovered 
by CREAM, 14 were replicated by 23andMe, whilst 16 of the 20 loci identified by 
23andMe were confirmed by CREAM. Surprisingly the same 25 genetic loci were 
identified in both studies with consistent direction of effect despite analysis on 
different scales, namely dioptres for CREAM (more negative on the scale indicative 
of more myopia) and hazard ratios (higher positive hazard ratios indicative of 
more severe myopia) for 23andMe (44, 45).  
 
Genome-wide association studies and myopia endophenotypes 
The most common type of myopia is axial myopia (lens-induced or lenticular 
myopia is seen in old age due to early nuclear cataract) and as such the axial length 
of the eye is a major determinant of refractive error. A number of researchers have 
therefore used this myopia proxy or ‘endophenotype’ in genetic association 
studies. The first of these, published in 2012, examined 4944 individuals of East 
and South East Asian ancestry (46).  One locus on 1q41 containing the zinc-finger 
pseudogene ZC3H11B reached genome wide significance (p = 4.38 x 10-10), 
although replication was not performed.  
 
A much larger GWAS meta-analysis for axial length comprising 12,531 Europeans 
and 8,216 Asians was published in 2013 (47). Eight, novel genome-wide 
significant loci were identified (RSPO1, C3orf26, LAMA2, GJD2, ZNRF3, CD55, MIP, 
ALPPL2) and the study also replicated the ZC3H11B gene. Relevantly, five of these 
loci had been previously associated in refractive error GWAS.  
 
Shared determination of an individual’s axial length and corneal curvature was 
identified in the Avon Longitudinal Study of Parents and Children (ALSPAC) and 
Singapore Chinese Eye Study, suggesting that shared genetic variants control 
these two parameters which contribute to the eye’s focus (48). A number of 
relatively small GWAS have been performed for corneal curvature in individuals 
of varying ancestry with identified associations  including FRAP1, PDGFRA (also 
associated with eye size), CMPK1 and RBP3 (49-52). More recently Miyake et al 
published a two-stage GWAS for three myopia-related traits: axial length, corneal 
curvature and refractive error (53). The study was performed on 9,804 Japanese 
individuals with trans-ethnic replication in Chinese and Caucasian individuals. A 
novel gene, WNT7B, was identified for axial length (p = 3.9 x 10-13) and corneal 
curvature (p = 2.9 x 10-40), whilst the previously reported association with GJD2 
and refractive error was replicated.  
 
Pathways implicated from genome-wide association studies in myopia 
Identifying genes associated with myopia is just the first step in maximizing 
information from GWAS to improve understanding of myopia etiology. Some 
individual biological mechanisms can be implicated from genes associated, but 
pathway analysis enables a more comprehensive, systems biology approach to 
understanding how associated genetic variants can ultimately influence ocular 
growth. Pathway analysis, however, does rely on previously published work on  
the functionality of certain genes.  
 
Functional pathways (or ontological classifications) implicated by the large GWAS 
on myopia to date have been clear and reproducible (54). Interestingly, they 
provide credible evidence that the genetic architecture is fairly consistent 
between two continental populations (European and Asian). As with many GWAS, 
the variants identified have not necessarily fallen within a gene but likely 
functional implications to proximal, relevant genes have been inferred. Although 
this is reasonable, there are other known factors, such as long-range distance 
equilibrium, which may mean alternate genes or pathways could equally be 
involved. Biological processes indicated from the CREAM meta-GWAS include 
neurotransmission (GRIA4), ion transport (KCNQ5), retinoic acid metabolism 
(RDH5), extracellular matrix remodeling (LAMA2, BMP2), and eye development 
(SIX6, PRSS56) (42). The 23andMe meta-GWAS similarly implied extracellular 
matrix remodeling (LAMA2, ANTXR2), the visual cycle (RDH5, RGR, KCNQ5), 
neuronal development (KCNMA1, RBFOX1, LRRC4C, NGL-1, DLG2, TJP2), eye and 
body growth (PRSS56, BMP4, ZBTB38, DLX1), and retinal ganglion cell projections 
(ZIC2, SFRP1) (43). Hysi et al reported that plasma membrane, cell-cell adhesion, 
synaptic transmission, calcium ion binding and cation channel activity were 
significantly over-represented in association with refractive error in two British 
cohorts (54).   
 
Whilst the biological processes implied by these genes may at first seem disparate, 
the protein products and end functions can be highly correlated. By examining 
known protein-protein interactions researchers have identified that in fact many 
of the genes implicated from the meta-GWAS in myopia are related to cell cycle 
and growth pathways such as the MAPK and TGF-beta/SMAD pathways, as shown 
in Figure 4 (45). This network analysis can provide greater insight into how 
refractive error develops, although it must be acknowledged that the risk loci 
identified from GWAS have not been shown to be causative in functional studies 
and therefore any pathway analysis is speculative. 
 
Figure 4 Network connections of genes associated with myopia. Genes identified 
in GWAS are in round grey nodes, linker elements in square nodes, MAPK & TGF-
beta/SMAD pathway elements are in orange, solid blue edges identify protein-
protein interactions and dashed blue edges symbolize corregulation relationships. 
Adapted from (45). 
 
Genome-wide association studies and gene-environment interactions 
Although myopia is a highly heritable trait, it is known that environmental factors 
are highly influential in determining myopia risk and must be driving the recent 
epidemic rise in prevalence (1). One of the most influential and highly replicated 
factors is education (4, 55-58); research suggest that those going onto higher 
education have double the myopia prevalence than those who leave school after 
primary education (4). Education has therefore been the primary environmental 
choice for gene-environment (GxE) interaction analyses in myopia. GxE studies 
acknowledge that individuals of a differing genotype may respond to 
environmental variation in differing ways; for example in some individuals an 
environmental exposure may trigger a certain gene to be unregulated whilst in 
others there is no effect. This method of analysis therefore has the potential to 
show how prior identified variants are modified by environmental exposure, but 
may also identify variants that were previously only suggestively associated with 
the disease of interest. 
 
Two research groups have examined this phenomenon by using the myopia-
associated variants from the CREAM meta-GWAS. In the first, individuals of 
European descent were categorized as having completed a primary, intermediate 
or higher education, and then assigned a polygenic risk score based on the 26 
myopia-associated variants from the CREAM meta-GWAS (59). There appeared to 
be an interaction between the effect of higher education and having a high genetic 
risk score; the odds ratio for myopia in those with high genetic risk completing 
higher education was 51.3 (95% CI 18.5 - 142.6) compared to an odds ratio of 7.2 
(95% CI 3.1 - 17.0) if only primary education was achieved. The combined effect 
of the two risk factors was far greater than the sum of the separate factors 
(synergy index = 4.2, 95% CI 1.9-9.5), providing evidence that an interaction effect 
between an environmental factor and an individual’s genotype was occurring. A 
similar analysis was performed on five Singaporean cohorts; this analysis 
identified three genes (DNAH9, GJD2 and ZMAT4-SFRP1) that were strongly 
associated with myopia in individuals achieving higher secondary or university 
education but that were either borderline or not statistically significant in 
individuals achieving lower secondary education or below (60). 
 
Implications from genome-wide association studies in myopia 
GWAS have enabled considerable progress in our understanding of what genetic 
variants are associated with myopia; the number of variants identified in the 
recent meta-GWAS far exceeds those identified by linkage and candidate gene 
studies. However the high heritability of refractive error and myopia which is 
between 70-80% (5-15), is only partly explained by the variants so far identified. 
In a European cohort the variants identified by the CREAM meta-GWAS explain 
only 3.4% of the variance of refractive error (42). This means approximately 75% 
of the expected heritability is ‘missing’, a recurrent problem in GWAS studies of 
complex diseases (27).  
 
In an attempt to identify missing variants for complex diseases, sample sizes need 
to be maximized. It is well known that small sample sizes reduce power and 
accuracy in capturing genetic associations. Since the publication of the major 
meta-GWAS in refractive error two studies, of relatively small size (less than 1,900 
individuals), have failed to fully replicate results (61, 62). Conversely, results from 
high-grade GWAS in refractive error were not replicated by the meta-analysis of 
CREAM; this may be due to phenotypic or genetic heterogeneity, or, more likely, 
lack of statistical power (63, 64). It must be acknowledged that underpowered 
GWAS may produce spurious or false-positive results. 
 
GWAS have confirmed that myopia is highly polygenic with significant variation 
in the allelic spectrum of identified loci; that is to say the minor allele frequency, 
indicative of how common the polymorphism is within a population, varied 
extensively within both the CREAM and 23andMe GWAS (45). However, the 
majority of variants had only a small effect on phenotypic variants with the highest 
effect sizes limited to the variants with the lowest minor allele frequency [Figure 
5]. GWAS, in its current form, is limited to assessing associations between a 
phenotype and common genetic variants. This means variants of lower allelic 
frequency (rare variants) but potentially large effect sizes have not been 
investigated.  
 
Figure 5 Minor allele frequency against effect size for the significant variants 
identified in the CREAM GWAS (adapted from 45). 
 
We can therefore infer that GWAS will never fully explain all the expected 
heritability from twin studies. A better means of estimating how much variance 
can potentially be explained by common genetic variation is to perform a genome-
wide complex trait analysis or SNP-based heritability (65-67). This technique 
allows estimation of how much inter-subject variation of a trait can be explained 
by all the available SNPs. The number of SNPs that have been genotyped or 
imputed for that individual limits the method, and therefore the SNP-based 
heritability corresponds to a lower-bound estimate. In a pediatric, British cohort 
SNP-based heritability was found to remain stable over childhood and, after 
adjustment for the lack of cycloplegia on the study participants, the SNP 
heritability, averaged over childhood, was 0.35 (standard error=0.09) (68). This 
would suggest that common genetic variants could explain 35% of variance, 
approximately half of the estimated heritability from twin studies. For comparison 
the authors point out that the variance explained by non-genetic risk factors, such 
as time indoors and time spent reading, is less than 1%. It therefore remains 
possible that more common variants of small effect could be found using common 
SNP-based association techniques and that there is merit in continuing to use the 
technique with ever larger sample sizes in an attempt to capture more genetic 
variants. Rarer variants (in the order of MAF = 1% to 5%), with potentially greater 
effect on phenotypic variation, may be identified with improved accuracy using 
the greater coverage conferred with the 1000 genomes haplotype map and larger 
sample sizes.  
 
One of the key questions for clinicians is whether our current understanding of 
myopia genetics allows prediction of future myopia status for children. Predicting 
disease risk is most commonly performed using receiver-operating characteristic 
(ROC) curves (69). This is a plot of the sensitivity of a test against 1-specificity of 
a test using all possible thresholds of high risk versus low risk. The area under the 
curve (AUC) is equal to the probability that a randomly identified individual with 
the disease has a higher risk than a randomly selected healthy individual. An AUC, 
or C statistic, is given as a fraction with a perfect test yielding an AUC of 1 and a 
test with no discriminatory power having an AUC of <0.5. The predictive accuracy 
of genetic-risk models varies extensively between diseases but to date confer little 
benefit over non-genetic risk prediction models (70). Age related macular 
degeneration has been an exception, with an AUC of 0.82 for the full combination 
of associated genetic variants identified through GWAS (71). The utility of 
prediction models for age-related macular degeneration in clinical practice has 
been further tested by adding in phenotypic and demographic information, such 
as age and smoking, which increases the AUC to 0.87 (72). However, in the 
majority of disease phenotypes an AUC of 0.5 to 0.7 is more commonly achieved 
(70), which confers little predictive value, and this is true for myopia at our 
current level of understanding of the genetic architecture. 
 
To increase the potential for predicting genetic risk entails greater understanding 
of the genetic architecture of myopia. As discussed, we estimate there are more 
common genetic variants to be identified and given that very low frequency 
variants are unlikely to contribute greatly to population variance, we can be 
optimistic that most of the phenotypic variation in myopia could be explained by 
common genetic variants (66). However, there are other genetic factors 
contributing to heritability. Genetic risk is a complex result of common genetic 
variation, rare genetic variation, gene-environment interactions, gene-gene 
interactions, epigenetics, and a host of other variations in our genetic make-up. 
Rare genetic variation requires new analysis techniques and more detailed 
sequencing of the genome of study participants. Fortunately next-generation 
sequencing has provided reduced cost of high-throughput, high coverage 
genotyping, enabling whole exome and whole genome examination. Higher-
density SNP chips have also been developed, either for higher coverage of the 
genome or exome-specifc. This means greater coverage of the genome but also 
increased accuracy as the reliance on imputation, typically poor for rare SNPs, is 
reduced. As methods for analyzing these vast datasets are refined, this will 
dramatically increase the potential for identification of rare variants and has 
already proved successful (73, 74). Interactions between our environment and 
our genome have already proved informative in myopia, whilst interactions 
between genes and other genetic architectural analysis techniques hold promise 
for the future. 
 
Expert commentary 
Genome-wide association studies in myopia have undoubtedly transformed our 
understanding of the genetic architecture of this complex trait. This is very 
relevant as myopia, already the most common eye condition, is increasing in 
prevalence throughout world. In light of the fact that myopia is a highly heritable 
trait, deeper understanding of how genetic variation leads to development of 
myopia is increasingly necessary.  
 
The genetic variants identified from the major GWAS in myopia have been clear 
and reproducible, providing credible evidence for their association. Biological 
processes indicated by the identified associations include neurotransmission, ion 
transport, retinoic acid metabolism, extracellular matrix remodeling, eye 
development, the visual cycle, neuronal development, eye and body growth, and 
retinal ganglion cell projections. Enrichment analysis suggests plasma membrane, 
cell-cell adhesion, synaptic transmission, calcium ion binding and cation channel 
activity appear to be significantly over-represented in refractive error. Many of 
the genetic associations are related to cell cycle and growth pathways such as the 
MAPK and TGF-beta/SMAD pathways. 
 
However, only around 3% of myopia variance is explained by the genetic variants 
identified to date. SNP-based heritability analysis suggests common genetic 
variation accounts for approximately 35% of myopia variance. Therefore, there is 
more work to be done in an effort to capture all associated common genetic 
variants. This requires larger samples and improved genotyping to reduce the 
burden on imputation, which ultimately can lead to poor ability to capture 
associated variants or conversely false-positive results. Alternate analysis 
techniques and proxy endophenotypes are being explored in an effort to further 
increase our ability to identify these variants. The interplay between genes, and 
genes and environment is being examined in relation to myopia with some 
success, shedding new light on how genetic variation may be modified and 
ultimately lead to myopia development in different individuals. It also important 
to acknowledge that twin-based estimates of heritability are much higher, at 70-
80%, and suggest that genetic factors other than common genetic variation may 
play a role.  
 
This paper provides a review of our current understanding into the genetics of 
myopia. There is much work still to be done, and this will be required before our 
ability to predict future development of myopia becomes a reality. GWAS provides 
the first step in our ability to identify novel loci and functional pathways. This 
must then be built upon with other genetic association modalities and the use of 
both animal models, although notably to date there are few genetic animal models 
for myopia, and pharmacological studies. Only then can researchers begin to 
target myopia development and reduce the burden from this common, sight-
threatening disease. 
   
Five-year view 
Despite significant progress in recent years, we still can only explain a very small 
proportion of myopia variance by genetic factors. In the next five years new 
approaches to try and capture more of the genetic variance will be employed. 
Firstly the simple approach of ‘bigger is better’ should be employed; ever-larger 
meta-analysis of GWAS studies from across the globe must be utilized in a 
collaborative format to increase the research community’s ability to find genes. 
This may involve using phenotype data that extends beyond the traditional 
modality of spherical equivalent into combining GWAS performed on proxy 
phenotypes and endophenotypes. 
 
Secondly a more detailed interrogation of the genome is required to identity rare 
genetic variants, and notably these variants may play a more significant role in 
myopia risk. This can be brought about through a number of existing methods. 
Using currently genotyped data the improved imputation capacity conferred by 
haplotype maps such as 1000 genomes should be employed to reduce 
imputational errors leading to false-negative and false-positive associations; 
notably both of the major GWAS studies on myopia to date are based on HapMap 
imputed data. An alternate method is employment of the improved genotyping 
ability that can be achieved with high-density chips and next-generation 
sequencing. These modalities achieve greater coverage of the genome, reduced 
genotyping errors and a reduced reliance on imputation. Although there are many 
obstacles to overcome such as data storage requirements for these vast files, 
refinement of analysis techniques, and establishment of how results are 
interpreted, they do provide a means to attempt to capture the known missing 
heritability in myopia.  
 
Finally alternate means of understanding the genetic architecture of myopia 
should be employed - extending beyond simple association methods to explore 
interactions and the effect of other ‘omics’. This may include incorporation of 
transcriptomics or metabolomics, for example, with existing association methods 
to allow a more systems biology based approach to understanding how genetic 
variation ultimately leads to myopia development.  
 
  
Key issues 
1. Myopia is the most common eye condition worldwide and the prevalence 
is increasing. 
2. Myopia has a complex trait with strong environmental risk factors such as 
education and lack of time spent outdoors, and a high heritability of 70-
80%. 
3. GWAS studies have enabled rapid association of common genetic variants 
with disease since 2005 in various traits, most successfully in age-related 
macular degeneration. 
4. Case-control high myopia GWAS studies have been largely performed in 
Asian populations with a number of genetic variants identified. 
5. The largest identification of variants for myopia was performed in two 
GWAS, by the CREAM consortium and 23andMe, published in 2013; the 
26 genetic loci by CREAM identified explain less than 5% of myopia 
variance. 
6. Functional pathways implicated by the genetic variants identified for 
myopia include plasma membrane, cell-cell adhesion, synaptic 
transmission, calcium ion binding and cation channel activity, with many 
of the genetic associations related to cell cycle and growth pathways. 
7. Gene by environment analyses suggest interaction effects do occur 
between the currently identified genetic variants and higher education, 
one of the strongest risk factors for myopia. 
8. In an attempt to capture more of the genetic variants for myopia, with the 
ultimate of aim of enabling risk prediction and developing targeted 
interventions, larger sample sizes are required with deeper coverage of 
the genome. 
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